Departments and Services | For Patients | Research & Trials | Education | Find a Doctor

Division of Infectious Disease
Division of Infections Disease
Fellowship Program
Clinical Programs
Penn CDC Prevention Epicenters Program
Clinical Trials
Botswana-UPenn Partnership
Adjunct Faculty
Administrative Contacts
Outpatient Clinics


faculty photo

Valerianna K. Amorosa, M.D.

Associate Professor of Clinical Medicine
Attending Physician, Hospital of the University of Pennsylvania
Attending Physician, Philadelphia Veteran's Affairs Medical Center (VAMC)
Associate Chief, ID Division Clinical Affairs , Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Hospital of the University of Pennsylvania
3 Silverstein, Suite E
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-823-5800
B.A. (Molecular Biology Cum Laude)
Princeton University, 1993.
Washington University in St. Louis, 1998.
Post-Graduate Training
Internship, Department of Medicine, University of Pennsylvania, 1998-1999.
Resident in Medicine, Department of Medicine, University of Pennsylvania, 1999-2001.
Postdoctoral Researcher, Hospital of the University of Pennsylvania, 2001-2001.
Infectious Diseases Fellowship, University of Pennsylvania, 2002-2004.
ABIM, Internal Medicine , 2011.
ABIM, Infectious Diseases, 2014.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Clinical research in HIV, HCV coinfection

Description of Clinical Expertise

HIV, HIV/HCV coinfection

Description of Other Expertise

Medical Education

Selected Publications

Petersen T, Lee YJ, Osinusi A, Amorosa VK, Wang C, Kang M, Matining R, Zhang X, Dou D, Umbleja T, Kottilil S, Peters MG: Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin AIDS Res Hum Retroviruses Page: Epub ahead of print, March 2016.

Hill A, Roberts T, Amorosa V, Pourmand K, Matthews G, Cooke G, Khan H, Cohn J. : Can HCV antigen testing replace HCV RNA analysis, for monitoring of DAA-based treatment for Hepatitis C? AASLD November 2015.

Gowda C, Sheikh U, Maier A, Chang KM, Kaplan DE, Lo Re III V, Amorosa V : Identifying barriers and potential strategies to improve HCC surveillance for HBV-infected veterans IDSA Oct 2015.

Cohn J, Roberts T, Amorosa V, Lemoine M, Hill A: Simplified diagnostic monitoring for hepatitis C, in the new era of direct-acting antiviral treatment Curr Opin HIV AIDS 10(5): 369-73, Sep 2015.

Ogdie A, Pang WG, Forde KA, Samir BD, Mulugeta L, Chang KM, Kaplan DE, Amorosa VK, Kostman JR, Reddy RK, Schumacher RH, Lo Re V 3rd: Prevalence and risk factors for patient-reported joint pain among patients with HIV/hepatitis C coinfection, hepatitis C monoinfection, and HIV monoinfection BMC Musculoskelet Disord 16(19): 93, April 2015.

Gluckman S, Amorosa V, Dummer S, Gordon S: ABIM Update in Infectious Diseases. ABIM Feb 2015.

Gowda C, Compher C, Amorosa VK, Lo Re V 3rd: Association between chronic hepatitis C virus infection and low muscle mass in US adults J Viral Hepat. (eds.). 21(12): 938-43, Dec 2014.

Shah NN, Harrison N, Stonecypher M, Frank D, Amorosa V, Svoboda J: Extracavitary primary effusion lymphoma initially presenting with hemophagocytic lymphohistocytosis . Clin Lymphoma Myeloma Leuk 14(5): e157-60, Oct 2014.

Gowda C, Compher C, Amorosa VK, Lo Re V 3rd: Association between chronic hepatitis C virus infection and low muscle mass in US adults J Viral Hepat Page: 12273, July 2014.

Cho H, Kikuchi M, Li Y, Nakamoto N, Amorosa V, Valiga ME, Chang KM: Induction of Multiple Immune Regulatory Pathways with Differential Impact in HCV/HIV Coinfection. Front Immunol 5(265): 265, Jul 2014.

back to top
Last updated: 06/30/2016
The Trustees of the University of Pennsylvania